US Capitol Capsule: Driving 'bad guys' out: A burden for industry, not taxpayers
This article was originally published in Scrip
Executive Summary
With the US trying, and failing, since 1988 to put an efficient national track-and-trace system in place to protect the biopharmaceutical supply chain against counterfeit products and so-called gray marketeers, 2013 could be the year it finally gets underway, with the House already adopting legislation and the Senate set to take up its bill in the coming weeks.